14 extractive question-and-answer pairs built from 66872871241561442115, published by ncdc.mohfw.gov.in. The source is a 5-page publication. Source-evidenced topics include seasonal influenza, clinical management protocol, category c, oseltamivir, high risk groups, pregnancy, post-partum, chronic respiratory disease. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. Question types in the export: 11 factual, 2 list, 1 relationship. 3 of the 14 pairs (21.4%) ask explanatory questions; the remaining 11 are factual or table-based questions. 100.00% of rows pass the corpus quality gate.
This dataset contains 14 extractive question-and-answer pairs derived from a 5-page publication by ncdc.mohfw.gov.in. The questions address topics such as seasonal influenza, clinical management protocols, high-risk groups, and specific treatments like oseltamivir. Each answer is a verbatim excerpt from the source document, ensuring traceability. The dataset includes factual, list-based, and relationship questions, with explanatory questions making up 21.4% of the total. It provides detailed guidance on dosage modifications, hygiene measures, and treatment protocols for various patient groups, including pregnant women and healthcare staff.
Browse more health datasets, including other records from the same source when available.
Explore Health datasets5 - Question and Answer Dataset
Economy · 159 rows
LRF Outlook for Second Half of SW Monsoon Season: 2010 - Question and Answer Dataset
Economy · 30 rows
air2 - Question and Answer Dataset
Health · 169 rows
Microsoft Word - Brief note on NCDC Cooler.doc - pdfMachine from Broadgun Software, http://pdfmachine.com, a great PDF writer utility! - Question and Answer Dataset
Health · 12 rows
NFHS-5 Dataset
Health · 3.8K+ rows
National Health Profile 2022 - Question and Answer Dataset
Health · 5.7K+ rows
National Health Profile 2022 — Question and Answer Dataset
Health · 5.7K+ rows
XVFC VOL I Main Report - Question and Answer Dataset
Health · 1.7K+ rows
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/ncdc-mohfw-gov-in-82fd4a61e2573b8d9eb4d064c1a8ba3e/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("ncdc-mohfw-gov-in-82fd4a61e2573b8d9eb4d064c1a8ba3e")
df.head()First 10 of 14 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_document | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| What modification is suggested for the dosage of oseltamivir in pre-term infants? | 1 – 3 mg/ kg/ dose BD | Weight-based Age Dosage <15kg 1-5 years 30 mg BD for 5 days 15-23kg 5-8 years 45 mg BD for 5 days 24-<40kg 8-12 years 60 mg BD for 5 days >40kg More than 12 years 75 mg BD for 5 days Infants (less than 1 year) < 3 months* 12 mg BD for 5 days 3-5 months 20 mg BD for 5 days 6-11 months 25 mg BD for 5 days * in pre term infants the dose may be modified from 1 – 3 mg/ kg/ dose BD Oseltamivir is also available as syrup (6-12mg per ml.). If needed dose & duration can be modified as per clinical condition | 357 | relationship | 0.970 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | Weight-based Age Dosage <15kg 1-5 years 30 mg BD for 5 days 15-23kg 5-8 years 45 mg BD for 5 days 24-<40kg 8-12 years 60 mg BD for 5 days >40kg More than 12 years 75 mg BD for 5 days Infants (less than 1 year) < 3 months* 12 mg BD for 5 days 3-5 months 20 mg BD for 5 days 6-11 months 25 mg BD for 5 days * in pre term infants the dose may be modified from 1 – 3 mg/ kg/ dose BD Oseltamivir is also available as syrup (6-12mg per ml.). | 3 | page=3,block=7 | 0.700 | valid |
| What hygiene measures should postpartum patients follow to reduce the risk of transmission to neonates? | frequent hand washing, use of masks | Patient to follow strict hygiene measures (frequent hand washing, use of masks) 2. If symptomatic, she should receive anti-viral Oseltamivir 3. | 43 | list | 0.820 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | Patient to follow strict hygiene measures (frequent hand washing, use of masks) 2. | 5 | page=5,block=0 | 0.700 | valid |
| What types of routine investigations may be required for evaluating and managing a patient with symptoms? | hematological, biochemical, radiological and microbiological tests | Routine investigations required for evaluation and management of a patient with symptoms as described above will be required. These may include hematological, biochemical, radiological and microbiological tests as necessary. | 144 | list | 0.820 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | These may include hematological, biochemical, radiological and microbiological tests as necessary. | 2 | page=2,block=2 | 0.700 | valid |
| What is recommended for pregnant women to prevent severe illness from influenza? | Vaccine is recommended for pregnant women, irrespective of the duration of the pregnancy. | For pregnant females Pregnant women are at increased risk for severe illness from influenza compared to non- pregnant women of reproductive age. Vaccine is recommended for pregnant women, irrespective of the duration of the pregnancy. In case of symptom development, anti- viral treatment should be initiated as early as possible (within 48 hours of illness onset) without awaiting results. Ante- natal steroids can be given for pre term labor. | 145 | factual | 0.570 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | For pregnant females Pregnant women are at increased risk for severe illness from influenza compared to non- pregnant women of reproductive age. Vaccine is recommended for pregnant women, irrespective of the duration of the pregnancy. In case of symptom development, anti- viral treatment should be initiated as early as possible (within 48 hours of illness onset) without awaiting results. | 5 | page=5,block=0 | 0.700 | valid |
| What is the recommended dose and duration of Oseltamivir for exposed health care staff? | Oseltamivir 75 mg OD for 7 days after the last exposure | 5. Discharge Policy: Patients may be discharged as soon as they are medically fit. Advise home isolation for a period of 7 days from the onset of illness. Use droplet precautions. No need for repeat testing. 6. For health care staff: 1. Use of universal Personal Protective Equipment (PPE) by all health care staff in isolation wards/ICU 2. Vaccination to be provided to health care workers as per National guidelines. 3. Consider antiviral chemoprophylaxis for exposed health care staff for 7 days following the last exposure during epidemic/outbreak situation Timing 1. Administer post exposure antiviral chemoprophylaxis as soon as possible after exposure, ideally within 48 hours after exposure. 2. Full-dose empiric antiviral treatment should be initiated as soon as symptoms occur, if treatment is indicated. Dosing and duration Oseltamivir 75 mg OD for 7 days after the last exposure. | 835 | factual | 0.570 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | Dosing and duration Oseltamivir 75 mg OD for 7 days after the last exposure. | 5 | page=5,block=0 | ||
| What is the recommended duration for home isolation after discharge? | 7 days from the onset of illness | 5. Discharge Policy: Patients may be discharged as soon as they are medically fit. Advise home isolation for a period of 7 days from the onset of illness. Use droplet precautions. No need for repeat testing. 6. For health care staff: 1. Use of universal Personal Protective Equipment (PPE) by all health care staff in isolation wards/ICU 2. Vaccination to be provided to health care workers as per National guidelines. 3. Consider antiviral chemoprophylaxis for exposed health care staff for 7 days following the last exposure during epidemic/outbreak situation Timing 1. Administer post exposure antiviral chemoprophylaxis as soon as possible after exposure, ideally within 48 hours after exposure. 2. Full-dose empiric antiviral treatment should be initiated as soon as symptoms occur, if treatment is indicated. Dosing and duration Oseltamivir 75 mg OD for 7 days after the last exposure. | 121 | factual | 0.570 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | Advise home isolation for a period of 7 days from the onset of illness. | 5 | page=5,block=0 | 0.700 | |
| What is the typical duration of fever and systemic symptoms in seasonal influenza? | 3 days, occasionally 5-8 days | Clinical Management Protocol for Seasonal Influenza (Revised on 25.02.2019) 1. Clinical Assessment: Patient will be assessed for categorization, those patients falling under the category A and B does not require hospitalization. Category C patients should be immediately hospitalized 1. Course of Illness: Fever and systemic symptoms usually last 3 days, occasionally 5-8 days, and gradually diminish. Cough and malaise may persist more than 2 weeks. Full recovery may take 1-2 weeks or longer, especially in the elderly. | 347 | factual | 0.570 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | Course of Illness: Fever and systemic symptoms usually last 3 days, occasionally 5-8 days, and gradually diminish. | 1 | page=1,block=0 | 0.700 | valid |
| When should antiviral treatment be initiated for pregnant women with influenza symptoms? | as early as possible (within 48 hours of illness onset) | For pregnant females Pregnant women are at increased risk for severe illness from influenza compared to non- pregnant women of reproductive age. Vaccine is recommended for pregnant women, irrespective of the duration of the pregnancy. In case of symptom development, anti- viral treatment should be initiated as early as possible (within 48 hours of illness onset) without awaiting results. Ante- natal steroids can be given for pre term labor. | 309 | factual | 0.570 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | In case of symptom development, anti- viral treatment should be initiated as early as possible (within 48 hours of illness onset) without awaiting results. | 5 | page=5,block=0 | 0.700 | valid |
| When should post-exposure antiviral chemoprophylaxis be administered to health care staff? | as soon as possible after exposure, ideally within 48 hours after exposure | 5. Discharge Policy: Patients may be discharged as soon as they are medically fit. Advise home isolation for a period of 7 days from the onset of illness. Use droplet precautions. No need for repeat testing. 6. For health care staff: 1. Use of universal Personal Protective Equipment (PPE) by all health care staff in isolation wards/ICU 2. Vaccination to be provided to health care workers as per National guidelines. 3. Consider antiviral chemoprophylaxis for exposed health care staff for 7 days following the last exposure during epidemic/outbreak situation Timing 1. Administer post exposure antiviral chemoprophylaxis as soon as possible after exposure, ideally within 48 hours after exposure. 2. Full-dose empiric antiviral treatment should be initiated as soon as symptoms occur, if treatment is indicated. Dosing and duration Oseltamivir 75 mg OD for 7 days after the last exposure. | 624 | factual | 0.570 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | Administer post exposure antiviral chemoprophylaxis as soon as possible after exposure, ideally within 48 hours after exposure. | ||||
| How long can cough and malaise persist in seasonal influenza? | more than 2 weeks | Clinical Management Protocol for Seasonal Influenza (Revised on 25.02.2019) 1. Clinical Assessment: Patient will be assessed for categorization, those patients falling under the category A and B does not require hospitalization. Category C patients should be immediately hospitalized 1. Course of Illness: Fever and systemic symptoms usually last 3 days, occasionally 5-8 days, and gradually diminish. Cough and malaise may persist more than 2 weeks. Full recovery may take 1-2 weeks or longer, especially in the elderly. | 432 | factual | 0.490 | https://ncdc.mohfw.gov.in/uploads/pdf/66872871241561442115.pdf | Cough and malaise may persist more than 2 weeks. | 1 | page=1,block=0 | 0.700 | valid |
Read straight from the file — download or use the API URL for the full dataset.
| 0.700 |
| valid |
| valid |
| 5 |
| page=5,block=0 |
| 0.700 |
| valid |